Fabry disease (FD) is a multisystemic X-linked lysosomal storage disease that causes the accumulation of neutral glycosphingolipids and globotriaosylceramide (GL-3) in lysosomes, and alpha-galactosidase-A activity is decreased [1]. Childhood-onset symptoms include periods of discomfort, acroparesthesia angiokeratomas, hypohidrosis, corneal opacity or verticillata, digestive tract issues, tinnitus, and hearing loss. The gene discussed is GLA; the disease is Fabry disease.